281 related articles for article (PubMed ID: 28477871)
1. [Immunotherapy: Activation of a system not a pathway].
Bernichon E; Rancoule C; Vallard A; Langrand-Escure J; Mery B; Guy JB; Magné N
Bull Cancer; 2017 May; 104(5):462-475. PubMed ID: 28477871
[TBL] [Abstract][Full Text] [Related]
2. Scientific contributions toward successful cancer immunotherapy in The Netherlands.
Melief CJ; Scheper RJ; de Vries IJ
Immunol Lett; 2014 Dec; 162(2 Pt B):121-6. PubMed ID: 25455598
[TBL] [Abstract][Full Text] [Related]
3. Calling cells to arms.
Elert E
Nature; 2013 Dec; 504(7480):S2-3. PubMed ID: 24352361
[No Abstract] [Full Text] [Related]
4. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
5. [Cancer immunotherapy: Rational and recent breakthroughs].
Granier C; Karaki S; Roussel H; Badoual C; Tran T; Anson M; Fabre E; Oudard S; Tartour E
Rev Med Interne; 2016 Oct; 37(10):694-700. PubMed ID: 27370898
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for melanoma.
Komenaka I; Hoerig H; Kaufman HL
Clin Dermatol; 2004; 22(3):251-65. PubMed ID: 15262312
[TBL] [Abstract][Full Text] [Related]
7. Bacteriology: a caring culture.
DeWeerdt S
Nature; 2013 Dec; 504(7480):S4-5. PubMed ID: 24352362
[No Abstract] [Full Text] [Related]
8. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
9. CTLA-4 blockade: autoimmunity as treatment.
Kapadia D; Fong L
J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
[No Abstract] [Full Text] [Related]
10. Cancer immunotherapy: accomplishments to date and future promise.
Helmy KY; Patel SA; Nahas GR; Rameshwar P
Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
12. Moving beyond monotherapy in the immunotherapeutic arena: prospects for combination therapies in lung cancer.
Antonia SJ
Clin Adv Hematol Oncol; 2016 Aug; 14(8):616-8. PubMed ID: 27487105
[No Abstract] [Full Text] [Related]
13. Cancer immunotherapeutics: evolution of monoclonal antibodies to peptide immunogens.
Murali R; Kieber-Emmons T
Monoclon Antib Immunodiagn Immunother; 2014 Jun; 33(3):179-82. PubMed ID: 24892996
[TBL] [Abstract][Full Text] [Related]
14. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy and the concept of a clinical cure.
Eggermont AM; Kroemer G; Zitvogel L
Eur J Cancer; 2013 Sep; 49(14):2965-7. PubMed ID: 23890942
[TBL] [Abstract][Full Text] [Related]
16. First person: Arlene Sharpe, MD, PhD: Scientist's work on PD-1 pathway paves the road to key cancer immunotherapies.
Printz C
Cancer; 2018 Oct; 124(19):3795-3796. PubMed ID: 30412303
[No Abstract] [Full Text] [Related]
17. State of Melanoma: An Historic Overview of a Field in Transition.
Karapetyan L; Kirkwood JM
Hematol Oncol Clin North Am; 2021 Feb; 35(1):1-27. PubMed ID: 33759768
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy innovator James Allison receives the 2015 Lasker~DeBakey Clinical Medical Research Award.
Hurst JH
J Clin Invest; 2015 Oct; 125(10):3732-6. PubMed ID: 26345422
[No Abstract] [Full Text] [Related]
19. The capacity of the immune system to control cancer.
Håkansson L
Eur J Cancer; 2009 Aug; 45(12):2068-70. PubMed ID: 19608409
[No Abstract] [Full Text] [Related]
20. Immunotherapy for Solid Malignancies.
Pawlik TM
Surg Oncol Clin N Am; 2019 Jul; 28(3):xiii-xiv. PubMed ID: 31079804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
